Discovery of Nose Drops Contributing to the Treatment of a Serious Type of Cancer

SadaNews - A team of researchers in the United States has developed a new non-invasive strategy to treat a severe type of brain cancer known as Glioblastoma.

The research team from the University of Washington and Northwestern University in Illinois has successfully created nasal drops containing a type of amino acid that stimulates the body's immune system to target cancer.

Researchers stated in comments reported by the website "SciTech Daily," which specializes in scientific research, that the new drug successfully stimulated the immune system within the body to target tumors during tests on laboratory mice.

Glioblastoma is one of the most common brain tumors in the United States, affecting three out of every one hundred thousand people. This cancer spreads rapidly in the patient's brain and often leads to the patient's death. Doctors say that one of the main reasons preventing the treatment of this cancer is the difficulty in delivering the drug to the brain.

Dr. Alexander Stieg, a neurologist at the University of Washington and director of research in the brain tumors department at the Siteman Cancer Center, stated: "We wanted to change this reality and develop non-invasive therapeutic methods to activate the immune system to attack cancer. "

He added, "Through this study, we have succeeded in creating nanoscale structures of nucleic acids using genetic engineering that can stimulate a strong immune response within the brain, redefining immunotherapeutic approaches to cancer tumors."